ON-DEMAND WEBINAR
LAA Closure: Pre-procedural Planning and Imaging
Dee Dee Wang, MD, FACC, FSCAI, FASE, FSCCT, Henry Ford Health System, Detroit, USA
Learn about the value of advanced Pre-procedural 3D Planning and 3D printing for Left Atrial Appendage Occlusion during this webinar presented by Dr. DeeDee Wang (Henry Ford Hospital) during Virtual CSI.
Dr. Wang and her team at Henry Ford Hospital have been long time users of Materialise Mimics Innovation Suite and now Mimics Enlight prior to their LAAO procedures and has helped the team understand the LAA anatomy of their patients more intimately which influences and inform their treatment strategies for each individual patient.
“Sizing is not enough with traditional CT. What we’re missing is computer-aided design. Because then you have technology to see depth, angulation, diameters, strength, constraints.” - Dr. Dee Dee Wang, Director of Structural Heart Imaging at the Henry Ford Hospital and Medical Director of 3D Printing at the Henry Ford Innovation Institute
Augment the predictability, trust the outcome.
Watch this webinar to:
-
Help shape the future of cardiovascular planning
-
Reliably estimate the risk for each patient
-
Benefit from AI to provide care fast
-
Enter your LAAO procedures with confidence
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.
L-102306
This content is intended for Health Care Professionals only.
Dee Dee Wang,
MD, FACC, FASE, FSCCT
Henry Ford Health System, USA
Dr. Wang is a Level 3 Cocats trained in echocardiography (with 3D TEE), nuclear, and cardiac CTA; and a Level 2 Cocats trained in cardiac MRI and cardiac PET. She specializes in interventional imaging in structural heart interventions including transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures. Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging and 3D printing for high-risk structural heart interventions.